Functional interplay between p53 acetylation and H1.2 phosphorylation in p53-regulated transcription

被引:0
|
作者
K Kim
K W Jeong
H Kim
J Choi
W Lu
M R Stallcup
W An
机构
[1] University of Southern California Keck School of Medicine,Department of Biochemistry and Molecular Biology
[2] Norris Comprehensive Cancer Center,undefined
[3] University of Southern California Keck School of Medicine,undefined
[4] The Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research,undefined
[5] University of Southern California Keck School of Medicine,undefined
来源
Oncogene | 2012年 / 31卷
关键词
H1.2; p53; acetylation; phosphorylation; DNA-PK; transcription;
D O I
暂无
中图分类号
学科分类号
摘要
Linker histone H1.2 has been shown to suppress p53-dependent transcription through the modulation of chromatin remodeling; however, little is known about the mechanisms governing the antagonistic effects of H1.2 in DNA damage response. Here, we show that the repressive action of H1.2 on p53 function is negatively regulated via acetylation of p53 C-terminal regulatory domain and phosphorylation of H1.2 C-terminal tail. p53 acetylation by p300 impairs the interaction of p53 with H1.2 and triggers a rapid activation of p53-dependent transcription. Similarly, DNA-PK-mediated phosphorylation of H1.2 at T146 enhances p53 transcriptional activity by impeding H1.2 binding to p53 and thereby attenuating its suppressive effects on p53 transactivation. Consistent with these findings, point mutations mimicking modification states of H1.2 and p53 lead to a significant increase in p53-induced apoptosis. These data suggest that p53 acetylation–H1.2 phosphorylation cascade serves as a unique mechanism for triggering p53-dependent DNA damage response pathways.
引用
收藏
页码:4290 / 4301
页数:11
相关论文
共 50 条
  • [31] Transcriptional control of human p53-regulated genes
    Riley, Todd
    Sontag, Eduardo
    Chen, Patricia
    Levine, Arnold
    NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2008, 9 (05) : 402 - 412
  • [32] Transcriptional control of human p53-regulated genes
    Todd Riley
    Eduardo Sontag
    Patricia Chen
    Arnold Levine
    Nature Reviews Molecular Cell Biology, 2008, 9 : 402 - 412
  • [33] A p53-regulated immune checkpoint relevant to cancer
    Zitvogel, Laurence
    Kroemer, Guido
    SCIENCE, 2015, 349 (6247) : 476 - 477
  • [34] p53 Acetylation: Regulation and Consequences
    Reed, Sara M.
    Quelle, Dawn E.
    CANCERS, 2015, 7 (01): : 30 - 69
  • [35] Insights into Regulators of p53 Acetylation
    Nagasaka, Mai
    Miyajima, Chiharu
    Aoki, Hiromasa
    Aoyama, Mineyoshi
    Morishita, Daisuke
    Inoue, Yasumichi
    Hayashi, Hidetoshi
    CELLS, 2022, 11 (23)
  • [36] Acetylation is indispensable for p53 activation
    Tang, Yi
    Zhao, Wenhui
    Chen, Yue
    Zhao, Yingming
    Gu, Wei
    CELL, 2008, 133 (04) : 612 - 626
  • [37] Functional Investigations of p53 Acetylation Enabled by Heterobifunctional Molecules
    Chen, Li-Yun
    Roy, Soumya Jyoti Singha
    Jadhav, Appaso M.
    Wang, Wesley W.
    Chen, Pei-Hsin
    Bishop, Timothy
    Erb, Michael A.
    Parker, Christopher G.
    ACS CHEMICAL BIOLOGY, 2024, 19 (09) : 1918 - 1929
  • [38] The interplay between mutant p53 and the mevalonate pathway
    Alejandro Parrales
    Elizabeth Thoenen
    Tomoo Iwakuma
    Cell Death & Differentiation, 2018, 25 : 460 - 470
  • [39] Complex interplay between p53 and chromosome stability
    Narkar, Akshay
    Johnson, Blake A.
    Li, Rong
    MOLECULAR & CELLULAR ONCOLOGY, 2021, 8 (04)
  • [40] Overexpression of the oncoprotein prothymosin α triggers a p53 response that involves p53 acetylation
    Kobayashi, T
    Wang, T
    Maezawa, M
    Kobayashi, M
    Ohnishi, S
    Hatanaka, K
    Hige, S
    Shimizu, Y
    Kato, M
    Asaka, M
    Tanaka, J
    Imamura, M
    Hasegawa, K
    Tanaka, Y
    Brachmann, RK
    CANCER RESEARCH, 2006, 66 (06) : 3137 - 3144